Literature DB >> 34643922

Nuclear receptor subfamily 5 group A member 2 (NR5A2): role in health and diseases.

Nikita Sandhu1, Satyavati Rana1, Kiran Meena2.   

Abstract

Nuclear receptors are the regulatory molecules that mediate cellular signals as they interact with specific DNA sequences. NR5A2 is a member of NR5A subfamily having four members (Nr5a1-Nr5a4). NR5A2 shows involvement in diverse biological processes like reverse cholesterol transport, embryonic stem cell pluripotency, steroidogenesis, development and differentiation of embryo, and adult homeostasis. NR5A2 haploinsufficiency has been seen associated with chronic pancreatitis, pancreatic and gastrointestinal cancer. There is a close relationship between the progression of pancreatic cancer from chronic pancreatitis, NR5A2 serving a common link. NR5A2 activity is regulated by intracellular phospholipids, transcriptional coregulators and post-translational modifications. The specific ligand of NR5A2 is unknown hence called an orphan receptor, but specific phospholipids such as dilauroyl phosphatidylcholine and diundecanoyl phosphatidylcholine act as a ligand and they are established drug targets in various diseases. This review will focus on the NR5A2 structure, regulation of its activity, and role in biological processes and diseases. In future, need more emphasis on discovering small molecule agonists and antagonist, which act as a drug target for therapeutic applications.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Chronic pancreatitis; NR5A2; Nuclear receptors; Pancreatic cancer and NR5A2 regulators

Mesh:

Substances:

Year:  2021        PMID: 34643922     DOI: 10.1007/s11033-021-06784-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  69 in total

Review 1.  Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunity.

Authors:  Thomas P Burris; Scott A Busby; Patrick R Griffin
Journal:  Chem Biol       Date:  2012-01-27

Review 2.  Emerging actions of the nuclear receptor LRH-1 in the gut.

Authors:  Pablo J Fernandez-Marcos; Johan Auwerx; Kristina Schoonjans
Journal:  Biochim Biophys Acta       Date:  2010-12-29

Review 3.  Nuclear receptor variants in liver disease.

Authors:  Vincent Zimmer; Roman Liebe; Frank Lammert
Journal:  Dig Dis       Date:  2015-05-27       Impact factor: 2.404

Review 4.  Therapeutic potential of Liver Receptor Homolog-1 modulators.

Authors:  Kyren A Lazarus; Dhilushi Wijayakumara; Ashwini L Chand; Evan R Simpson; Colin D Clyne
Journal:  J Steroid Biochem Mol Biol       Date:  2012-01-14       Impact factor: 4.292

Review 5.  Nuclear receptors and lipid physiology: opening the X-files.

Authors:  A Chawla; J J Repa; R M Evans; D J Mangelsdorf
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

Review 6.  The Orphan Nuclear Receptors Steroidogenic Factor-1 and Liver Receptor Homolog-1: Structure, Regulation, and Essential Roles in Mammalian Reproduction.

Authors:  Marie-Charlotte Meinsohn; Olivia E Smith; Kalyne Bertolin; Bruce D Murphy
Journal:  Physiol Rev       Date:  2019-04-01       Impact factor: 37.312

Review 7.  Emerging roles for LXRs and LRH-1 in female reproduction.

Authors:  Kevin Mouzat; Silvère Baron; Geoffroy Marceau; Françoise Caira; Vincent Sapin; David H Volle; Serge Lumbroso; Jean-Marc Lobaccaro
Journal:  Mol Cell Endocrinol       Date:  2012-06-28       Impact factor: 4.102

Review 8.  LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis.

Authors:  Elisabeth Fayard; Johan Auwerx; Kristina Schoonjans
Journal:  Trends Cell Biol       Date:  2004-05       Impact factor: 20.808

Review 9.  Nuclear receptors and the control of metabolism.

Authors:  Gordon A Francis; Elisabeth Fayard; Frédéric Picard; Johan Auwerx
Journal:  Annu Rev Physiol       Date:  2002-05-01       Impact factor: 19.318

10.  A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects.

Authors:  Jae Man Lee; Yoon Kwang Lee; Jennifer L Mamrosh; Scott A Busby; Patrick R Griffin; Manish C Pathak; Eric A Ortlund; David D Moore
Journal:  Nature       Date:  2011-05-25       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.